Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole Effect on Pritelivir PK
NCT05513625Phase 1Completed
- Sponsor
- AiCuris
- Start
- Jul 2020
- Primary completion
- Oct 2020
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pritelivir in herpes simplex virus infection, sponsored by AiCuris. Primary endpoints: PK - Maximum Plasma Concentration (Cmax) at 15 days and PK - Area Under the Curve (AUC) at 15 days. Started Jul 2020; status: completed.
02
Drugs
pritelivir
03
Conditions
herpes simplex virus infection
Beyond the preview
Go deeper on NCT05513625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05513625.